U.S. Pension Benefits was LivaNova’s largest region in fiscal 2025, bringing in $739.46M of $1.39B (53%).
| Geography | FY 2014 | FY 2015 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pension Benefits | $546.17M | $609.85M | $683.49M | $739.46M | |||||||||
| U.S | — | — | — | — | |||||||||
| U.S. Plans | — | — | — | — | |||||||||
| United States | — | — | — | — | |||||||||
| Rest Of World | $266.18M | $299.12M | $331.33M | $372.67M | |||||||||
| Europe | $178.84M | $214.85M | $222.92M | $266.07M | |||||||||
| Other | $30.61M | $29.72M | $15.70M | $9.86M | |||||||||
| Total | $1.02B | $1.15B | $1.25B | $1.39B |
LivaNova brought in $1.39B from its four regions in fiscal 2025, the year ended December 31, 2025. That was up 10.7% from $1.25B in fiscal 2024. U.S. Pension Benefits was the largest at $739.46M (53.3%), ahead of Rest Of World at $372.67M (26.8%) and Europe at $266.07M (19.2%). The remaining region, Other, brought in $9.86M.
Compared with fiscal 2024, Europe grew fastest, up 19.4% to $266.07M. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $1.02B to $1.39B, a compound annual growth rate of 10.8%. U.S. Pension Benefits' share held steady at about 53.3%.
Cardiopulmonary was LivaNova’s largest segment in fiscal 2025, bringing in $785.39M of $1.39B (57%).
| Segment | FY 2014 | FY 2015 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | — | — | — | — | |||||||||
| Cardiopulmonary | $514.20M | $604.11M | $683.51M | $785.39M | |||||||||
| Neuromodulation | $476.99M | $519.71M | $554.22M | $592.81M | |||||||||
| Cv | — | — | — | — | |||||||||
| Cardiac Surgery | — | — | — | — | |||||||||
| Nm | — | — | — | — | |||||||||
| Advanced Circulatory Support | — | — | — | — | |||||||||
| Other | $30.61M | $29.72M | $15.70M | $9.86M | |||||||||
| Corporate, Non-Segment | — | — | — | — | |||||||||
| Total | $1.02B | $1.15B | $1.25B | $1.39B |
LivaNova brought in $1.39B from its three segments in fiscal 2025, the year ended December 31, 2025. That was up 10.7% from $1.25B in fiscal 2024. Cardiopulmonary was the largest at $785.39M (56.6%), ahead of Neuromodulation at $592.81M (42.7%) and Other at $9.86M (0.7%).
Compared with fiscal 2024, Cardiopulmonary grew 14.9% to $785.39M and Neuromodulation grew 7.0% to $592.81M. From fiscal 2022 to 2025, combined revenue from these segments grew from $1.02B to $1.39B, a compound annual growth rate of 10.8%. Cardiopulmonary's share of the total rose from 50.3% to 56.6%.
Continuing Operations was LivaNova’s largest revenue line in fiscal 2017, bringing in $1.01B of $1.01B (100%).
| Operating Activities | FY 2015 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|
| Continuing Operations | $291.56M | $362.40M | $963.12M | $1.01B |
| Corporate, Non-Segment | — | $841.00K | $1.74M | $1.78M |
| Total | $291.56M | $363.24M | $964.86M | $1.01B |
LivaNova brought in $1.01B from its two revenue lines in fiscal 2017, the year ended December 31, 2017. That was up 4.9% from $964.86M in fiscal 2016. Continuing Operations was the largest at $1.01B (99.8%), ahead of Corporate, Non-Segment at $1.78M (0.2%).
LivaNova (LIVN) reports its revenue by geography, by segment and by operating activities. In fiscal 2025, U.S. Pension Benefits was its largest region, bringing in $739.46M (53.3% of the total), followed by Rest Of World at $372.67M (26.8%).
U.S. Pension Benefits was LivaNova's largest region in fiscal 2025, bringing in $739.46M, or 53.3% of the $1.39B total across its four regions.
Cardiopulmonary was LivaNova's largest segment in fiscal 2025, bringing in $785.39M, or 56.6% of the $1.39B total across its three segments.
Continuing Operations was LivaNova's largest revenue line in fiscal 2017, bringing in $1.01B, or 99.8% of the $1.01B total across its two revenue lines.
Among LivaNova's regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 19.4% from $222.92M to $266.07M.
Every figure comes from LivaNova's annual financial filings, as reported. Each line keeps the name LivaNova gives it, and years follow its fiscal calendar.
LivaNova's revenue by geography goes back to fiscal 2014, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.